119 related articles for article (PubMed ID: 2970505)
1. Localization of the receptor binding site of IFN-alpha 2b.
Siemers R; Hensley L; Ozer H
J Immunol; 1988 Sep; 141(5):1550-5. PubMed ID: 2970505
[TBL] [Abstract][Full Text] [Related]
2. Three separate epitopes on human IFN-alpha variants defined by monoclonal antibodies and their role in the binding to receptors.
Kandefer-Szerszeń M; Lundgren E
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):241-6. PubMed ID: 1284462
[TBL] [Abstract][Full Text] [Related]
3. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F
J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126
[TBL] [Abstract][Full Text] [Related]
4. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies that distinguish between subspecies of human interferon-alpha and that detect interferon oligomers.
Shearer M; Taylor-Papadimitriou J; Griffin D; Balkwill F
J Immunol; 1984 Dec; 133(6):3096-101. PubMed ID: 6491281
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis.
Overall ML; Hertzog PJ
Mol Immunol; 1992 Mar; 29(3):391-9. PubMed ID: 1372957
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to human alpha-interferon and their use for affinity chromatography.
Novick D; Eshhar Z; Rubinstein M
J Immunol; 1982 Nov; 129(5):2244-7. PubMed ID: 7119444
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the antitumor activity of human recombinant interferon alpha-2b in vitro].
Haraguchi S; Koide Y; Matsuo T; Yoshida TO
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3236-43. PubMed ID: 2946265
[TBL] [Abstract][Full Text] [Related]
9. Immunoassay for the quantitation of human leukocyte interferon.
Berthold W; Merk W; Adolf GR
Arzneimittelforschung; 1985; 35(1A):364-9. PubMed ID: 4039175
[TBL] [Abstract][Full Text] [Related]
10. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
[TBL] [Abstract][Full Text] [Related]
11. Epitopes of human interferon-alpha defined by the reaction of monoclonal antibodies with alpha interferons and interferon analogues.
Taylor-Papadimitriou J; Shearer M; Griffin D
J Immunol; 1987 Nov; 139(10):3375-81. PubMed ID: 2445813
[TBL] [Abstract][Full Text] [Related]
12. Single high affinity binding of interferon alpha 2 to receptors on human lymphoblastoid cells: internalization and inactivation of receptors.
Faltynek CR; McCandless S; Baglioni C
J Cell Physiol; 1985 Jun; 123(3):459-66. PubMed ID: 3157692
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor.
Sheehan KC; Calderon J; Schreiber RD
J Immunol; 1988 Jun; 140(12):4231-7. PubMed ID: 2453573
[TBL] [Abstract][Full Text] [Related]
14. Murine tumor cells expressing the gene for the human interferon alpha beta receptor elicit antibodies in syngeneic mice to the active form of the receptor.
Uzé G; Lutfalla G; Eid P; Maury C; Bandu MT; Gresser I; Mogensen K
Eur J Immunol; 1991 Feb; 21(2):447-51. PubMed ID: 1825636
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
16. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
Redlich PN; Grossberg SE
J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
[TBL] [Abstract][Full Text] [Related]
17. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.
Nanduri J; Vroegop SM; Buxser SE; Neet KE
J Neurosci Res; 1994 Mar; 37(4):433-44. PubMed ID: 7517456
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against IFN gamma-binding proteins recognize a member of IFN alpha R complex.
Bello I; Rodes L; Saura PL
Biochem Biophys Res Commun; 2001 Feb; 280(4):1197-202. PubMed ID: 11162654
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against a peptide representative of a conserved region of human IFN-alpha. Differential effects on the antiviral and antiproliferative effects of IFN.
Barasoain I; Portolés A; Aramburu JF; Rojo JM
J Immunol; 1989 Jul; 143(2):507-12. PubMed ID: 2738400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
